Oncor/NNP Inc./NNP ,/, Gaithersburg/NNP ,/, Md./NNP ,/, said/VBD it/PRP received/VBD approval/NN from/IN the/DT U.S./NNP Food/NNP and/CC Drug/NNP Administration/NNP to/TO market/VB a/DT genetic/JJ test/NN that/WDT will/MD assist/VB in/IN diagnosis/NN and/CC treatment/NN of/IN leukemia/NN and/CC lymph/NN cancer/NN ./.
The/DT B$$T/NNP gene/NN rearrangement/NN test/NN is/VBZ more/RBR accurate/JJ than/IN existing/VBG tests/NNS for/IN diagnosing/VBG the/DT type/NN of/IN cancer/NN ,/, whether/IN it/PRP has/VBZ spread/VBN or/CC whether/IN there/EX is/VBZ a/DT recurrence/NN following/VBG treatment/NN ,/, said/VBD Oncor/NNP President/NNP Stephen/NNP Turner/NNP ./.
Mr./NNP Turner/NNP said/VBD the/DT test/NN initially/RB will/MD be/VB used/VBN in/IN conjunction/NN with/IN biopsies/NNS and/CC other/JJ tests/NNS ,/, but/CC eventually/RB might/MD become/VB the/DT benchmark/NN for/IN tumor/NN analysis/NN ./.
Mr./NNP Turner/NNP said/VBD the/DT test/NN will/MD be/VB shipped/VBN in/IN #/CD days/NNS to/TO hospitals/NNS and/CC clinical/JJ laboratories/NNS ./.
Dr./NNP Wyndham/NNP Wilson/NNP ,/, a/DT cancer/NN treatment/NN specialist/NN at/IN the/DT National/NNP Cancer/NNP Institute/NNP ,/, said/VBD the/DT test/NN is/VBZ widely/RB used/VBN in/IN research/NN centers/NNS but/CC is/VBZ n't/RB having/VBG a/DT major/JJ impact/NN because/IN it/PRP is/VBZ only/RB occasionally/RB useful/JJ in/IN choosing/VBG the/DT most/JJS effective/JJ treatment/NN ./.
But/CC the/DT test/NN may/MD prove/VB to/TO be/VB more/RBR sensitive/JJ in/IN determining/VBG whether/IN a/DT tumor/NN has/VBZ spread/VBN or/CC returned/VBN following/VBG treatment/NN ,/, Dr./NNP Wilson/NNP said/VBD ./.
``/`` We/PRP do/VBP n't/RB know/VB yet/RB how/WRB useful/JJ it/PRP 's/VBZ going/VBG to/TO be/VB ,/, ''/'' he/PRP said/VBD ./.
Oncor/NNP ,/, a/DT six-year-old/JJ developer/NN of/IN genetic/JJ medical/JJ tests/NNS ,/, projects/VBZ that/IN the/DT cancer/NN test/NN will/MD help/VB it/PRP to/TO post/VB its/PRP$ first-ever/JJ profit/NN during/IN the/DT first/JJ quarter/NN of/IN #/CD ,/, Mr./NNP Turner/NNP said/VBD ./.
The/DT company/NN will/MD charge/VB $/$ #/CD for/IN a/DT test/NN and/CC projects/VBZ about/IN $/$ #/CD million/CD in/IN revenue/NN from/IN the/DT test/NN during/IN the/DT first/JJ #/CD months/NNS of/IN marketing/NN ,/, he/PRP said/VBD ./.
